MA, FRCP (Paeds, UK), PhD, FRCPath
Professor of Haematology and Transfusion Medicine
- Consultant Haematologist
Clinical indications of blood components, through systematic reviews and clinical studies/trials.
Dr Simon Stanworth is a Consultant Haematologist for NHSBT at the John Radcliffe Hospital (Oxford University Hospitals Foundation Trust), and honorary senior clinical lecturer at the University of Oxford. He has over 15 years of clinical research experience since gaining his PhD in 1995 from the University of Oxford. His research is centred on clinical indications of blood transfusion components, through systematic reviews and clinical studies/trials. Highlights have included several international randomised trials published in NEJM. He has published extensively, having over 150 peer-reviewed research articles, with an h-index 48; more recently he has been involved with 5 national guidelines. He is secretary of the South Central Regional Transfusion Committee. Dr Stanworth is a current scientific member of the BEST Collaborative from 2007.
Platelet transfusion and anticoagulation in haematological cancer-associated thrombosis and thrombocytopenia: the CAVEaT multi-centre prospective cohort.
Booth S. et al, (2022), J Thromb Haemost
Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial.
REMAP-CAP Writing Committee for the REMAP-CAP Investigators None. et al, (2022), JAMA
Neonatal platelet transfusions: New evidence and the challenges of translating evidence-based recommendations into clinical practice.
Sola-Visner M. et al, (2022), J Thromb Haemost, 20, 556 - 564
The EHA Research Roadmap: Transfusion Medicine
Stanworth SJ. et al, (2022), HemaSphere, 6
Effectiveness of Enhanced Performance Feedback on Appropriate Use of Blood Transfusions: A Comparison of 2 Cluster Randomized Trials.
Stanworth SJ. et al, (2022), JAMA Netw Open, 5